Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3479153 | 1.00 | ALOX5 (0.59) | ALOX5SMN1; SMN2TRPA1ALDH1A1CYP3A4 | |
| SCHEMBL4157460 | 1.00 | ALOX5 (0.59) | ALOX5SMN1; SMN2TRPA1ALDH1A1CYP3A4 | |
| SCHEMBL3479376 | 0.90 | ALOX5 (0.62) | ALOX5SMN1; SMN2TRPA1ALDH1A1CYP3A4 | |
| SCHEMBL7055929 | 0.89 | ALOX5 (0.48) | ALOX5SMN1; SMN2TRPA1ALDH1A1CYP3A4 | |
| SCHEMBL23034161 | 0.87 | TSHR (0.48) | ALOX5SMN1; SMN2TRPA1ALDH1A1CYP3A4 | |
| SCHEMBL2523561 | 0.87 | ALOX5 (0.46) | ALOX5SMN1; SMN2TRPA1ALDH1A1CYP3A4 | |
| SCHEMBL11519491 | 0.87 | TSHR (0.48) | ALOX5SMN1; SMN2TRPA1ALDH1A1CYP3A4 | |
| SCHEMBL2516791 | 0.87 | ALOX5 (0.46) | ALOX5SMN1; SMN2TRPA1ALDH1A1CYP3A4 | |
| SCHEMBL9294752 | 0.87 | ALOX5 (0.46) | ALOX5SMN1; SMN2TRPA1ALDH1A1CYP3A4 | |
| SCHEMBL11500482 | 0.87 | ALOX5 (0.46) | ALOX5SMN1; SMN2TRPA1ALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090069407-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR REPELLING BLOOD-FEEDING ARTHROPODS AND DETERRING THEIR LANDING AND FEEDING | PHERO TECH INTERNATIONAL INC. (CA) | 2009-03-12 | — | — | US | claimed |
| US-8889731-B2 | Compounds, compositions and methods for repelling blood-feeding arthropods and deterring their landing and feeding | CONTECH ENTERPRISES INC. (US) | 2014-11-18 | — | — | US | disclosed |
| EP-2142500-A1 | ALLYL SULFIDE COMPOUNDS, AND COMPOSITIONS AND METHODS USING SAID COMPOUNDS FOR REPELLING BLOOD-FEEDING ARTHROPODS | Contech Enterprises Inc. (CA) | 2010-01-13 | — | — | EP | disclosed |
| US-20090069407-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR REPELLING BLOOD-FEEDING ARTHROPODS AND DETERRING THEIR LANDING AND FEEDING | PHERO TECH INTERNATIONAL INC. (CA) | 2009-03-12 | — | — | US | disclosed |
| WO-2008116321-A1 | ALLYL SULFIDE COMPOUNDS, AND COMPOSITIONS AND METHODS USING SAID COMPOUNDS FOR REPELLING BLOOD-FEEDING ARTHROPODS | CONTECH ENTERPRISES INC. (CA) | 2008-10-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090069407-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR REPELLING BLOOD-FEEDING ARTHROPODS AND DETERRING THEIR LANDING AND FEEDING | SAV1, CUTA, SOAT1 | ALOX5 855/4885SMN1; SMN2 1833/4885TRPA1 169/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.